HMR’s for economic boost
September 21, 2010
HOME Medicines Reviews can
result in a significant decrease in
healthcare utilisation costs,
according to the results of the
Economic Value of Home
Medicines Reviews study, conducted
by the University of Tasmania.
According to researchers, HMRs
provide an “excellent opportunity
for pharmacists to identify and
manage targeted patients likely to
be for example, at high risk of
adverse drug events , through
improved patient medication
management, knowledge and
compliance.
“Ultimately, the targeted HMRs
ensured improved quality of life for
those patients and avoided heavy
cost burdens on the health system
including potentially preventable
hospitalisations,” a statement from
the researchers said.
Recommendations for moving
forward include the development
of resources for accredited
pharmacists to ensure that HMRs
meet the expectations of GPs and
patients (with an increased focus
on individualising patient therapy).
The HMR report is available to
view at www.guild.org/research.
The above article was sent to subscribers in Pharmacy Daily's issue from 21 Sep 10To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 21 Sep 10
